Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 USD | +2.77% | -4.50% | +67.80% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.80% | 555M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.13% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Needham Adjusts Price Target on Taysha Gene Therapies to $5 From $6, Keeps Buy Rating